Why is Incyte Corp. ?
1
High Management Efficiency with a high ROE of 13.05%
2
The company is Net-Debt Free
3
Healthy long term growth as Net Sales has grown by an annual rate of 14.03% and Operating profit at 53.05%
4
With a growth in Net Profit of 91.73%, the company declared Very Positive results in Mar 26
- The company has declared positive results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 1,516.78 MM
- ROCE(HY) Highest at 30.82%
- RAW MATERIAL COST(Y) Fallen by 1.14% (YoY)
5
With ROE of 22.40%, it has a attractive valuation with a 3.48 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 47.70%, its profits have risen by 4556%
How much should you buy?
- Overall Portfolio exposure to Incyte Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Incyte Corp. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Incyte Corp.
47.7%
2.22
33.25%
S&P 500
22.99%
1.78
12.93%
Quality key factors
Factor
Value
Sales Growth (5y)
14.03%
EBIT Growth (5y)
53.05%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.65
Sales to Capital Employed (avg)
1.03
Tax Ratio
93.24%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
43.95%
ROE (avg)
13.05%
Valuation Key Factors 
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
3.48
EV to EBIT
10.72
EV to EBITDA
10.03
EV to Capital Employed
9.02
EV to Sales
2.80
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
84.08%
ROE (Latest)
22.40%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Bullish
Bullish
Technical Movement
14What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 1,516.78 MM
ROCE(HY)
Highest at 30.82%
RAW MATERIAL COST(Y)
Fallen by 1.14% (YoY
CASH AND EQV(HY)
Highest at USD 7,596.43 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -70.72 %
NET PROFIT(Q)
At USD 317.86 MM has Grown at 90.42%
-2What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 5.24 times
Here's what is working for Incyte Corp.
Operating Cash Flow
Highest at USD 1,516.78 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Profit
At USD 317.86 MM has Grown at 90.42%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Cash and Eqv
Highest at USD 7,596.43 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -70.72 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by 1.14% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Incyte Corp.
Inventory Turnover Ratio
Lowest at 5.24 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio






